Combination chemotherapy of infectious diseases. Chairman's summing-up and conclusions.
D001424:Bacterial Infections / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D004338:Drug Combinations; D004341:Drug Evaluation; D004405:Dysentery, Bacillary / Q000188:drug therapy; D005260:Female; D005759:Gastroenteritis / Q000188:drug therapy; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D008288:Malaria / Q000188:drug therapy; D008297:Male; D010033:Otitis Media / Q000188:drug therapy; D010284:Paratyphoid Fever / Q000188:drug therapy; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy; D011472:Prostatitis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use*; D014435:Typhoid Fever / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole